All Press Releases
PILA PHARMA announces positive phase 2a results in people with type 2 diabetes and strengthening of the organization
PILA PHARMA announces positive phase 2a results in people with type 2 diabetes and strengthening of the organization
2018, 11, 07 — PILA PHARMA Press Release
Malmö, Sweden, 7th November 2018 PILA PHARMA announces good safety of XEN-D0501 following single doses in patients with type 2 diabetes PILA PHARMA AB, a pharmaceutical company based in Malmö, Sweden, is pleased to announce that on November 1st, 2018, the dosing of patients in its first trial PP-CT01, studying the safety and tolerability of XEN-D0501 in patients with type…
2017, 12, 06 — PILA PHARMA Press Release
Malmö, Sweden, 6th December 2017 PILA PHARMA passes the start-up phase, prepares for efficacy trials and increases focus on 'Effective and Affordable Medicine' by electing the health economist Ulrikka Klarskov Kjær to the Board of Directors PILA PHARMA, founded in 2014, now counts +10 core members and has thus passed the "start-up" phase. "We are about to move out of…